HealthStaffingGroup.com

QMSR and Medical Device Quality Leadership: What Employers Should Define

FDA’s Quality Management System Regulation (QMSR) took effect on February 2, 2026. It incorporates ISO 13485:2016 into the medical-device current good manufacturing practice framework in 21 CFR Part 820 and uses a revised FDA inspection program. For employers, the practical planning question is: who owns the quality-system work, records, and cross-functional coordination that investigators may examine?

This is an employer role-planning guide, not a compliance assessment. The FDA’s regulation applies to finished-device manufacturers intending to commercially distribute medical devices, with certain accessories also treated as finished devices. Confirm applicability for your products and operations with qualified regulatory counsel or advisors.

What changed under the QMSR

The QMSR became effective February 2, 2026, and incorporates by reference ISO 13485:2016 while retaining applicable FDA requirements. FDA also stopped using the former Quality System Inspection Technique (QSIT) and began using its updated Inspection of Medical Device Manufacturers Compliance Program, 7382.850.

FDA’s QMSR frequently asked questions state that investigators may review records that are part of a manufacturer’s quality management system, including records created before the effective date. FDA specifically says it may inspect management-review records, quality-audit records, and supplier-audit reports. These items were previously exempt from review under the former rule’s records provision.

The FDA recommends that firms be prepared to discuss and provide records demonstrating compliance. The agency’s guidance describes regulatory requirements and inspection expectations; it does not prescribe one company org chart or a single job title for managing them.

Translate the inspection scope into clear ownership

Before opening a search or changing a reporting line, map the work already being done. The goal is to identify accountable owners and handoffs, not to assume every organization needs a new position.

  • Quality-system records: Identify who maintains the records, who can retrieve them, and how the company explains their relationship to the quality management system.
  • Management review: Clarify who prepares the review, who participates, how decisions are documented, and who tracks resulting actions.
  • Internal quality audits: Define responsibility for the audit program, follow-up, and clear documentation of findings and corrective actions.
  • Supplier audits: Establish who coordinates supplier oversight, retains the relevant reports, and works with procurement, engineering, manufacturing, and quality teams.
  • Legacy records: Decide who evaluates records created before February 2, 2026, and how the company will explain their fit with current requirements.

These are employer planning prompts based on FDA’s stated record-review scope. They are not a list of roles or duties mandated by the FDA.

Build the hiring brief around the actual gap

If the ownership map reveals a leadership or capacity gap, describe the work before selecting a title. A useful role brief answers:

  1. Which products, sites, and quality-system processes fall within the role’s scope?
  2. Will the person lead the quality system, own a defined part of it, or coordinate contributors across functions?
  3. What experience is needed with medical-device quality systems, ISO 13485, audits, supplier oversight, management review, or inspection preparation?
  4. Which decisions can the person make, and how will quality work connect with regulatory affairs, engineering, supplier quality, and manufacturing?
  5. What evidence will show that the person can perform the role’s defined responsibilities?

Do not screen solely for the phrase “QMSR experience.” Match requirements to the employer’s products, existing system, team structure, and the responsibilities of the specific role. A company may be able to clarify ownership among its current team; another may decide a dedicated permanent hire is appropriate. That choice depends on the organization’s actual needs.

Keep the search aligned with the role

Quality and regulatory responsibilities can overlap, but the employer should state where accountability sits and how the functions work together. Define whether the search is for a quality-systems leader, a supplier-quality specialist, an internal-audit leader, a regulatory-affairs executive, or a role with a carefully scoped combination of responsibilities.

For permanent medical-device quality and regulatory searches, see HealthStaffingGroup’s Medical Device Quality & Regulatory recruiting practice. For broader medical-device, MedTech, and medical-manufacturing roles, visit the HSG MedTech practice hub.

Sources

Last checked October 22, 2026. This article summarizes public FDA information for employer workforce planning and is not legal, regulatory, or compliance advice.

Facebook
Twitter
LinkedIn
WhatsApp
Pinterest
Reddit
Facebook
Twitter
LinkedIn
WhatsApp
Pinterest
Reddit

Subscribe for Update

QMSR and Medical Device Quality Leadership: What Employers Should Define

FDA’s QMSR inspection and record-review scope can help medical-device employers clarify ownership across quality leadership,…

October 22, 2026

Define the Mandate Before Hiring a Medical Device Commercial Executive

A practical brief for medical-device employers defining a senior commercial leader’s mandate, decision rights, team,…

October 22, 2026

Medical Device Sales Hiring: A Role Scorecard for Employers

Before recruiting medical device sales talent, define the product, customer, sales motion, territory, support responsibilities…

October 22, 2026

Why Medical Device Companies Struggle to Hire Regulatory Affairs Leaders (And How to Solve It)

The medical device industry has never been more innovative or more heavily regulated. Artificial intelligence,…

July 28, 2026

Why Home Health Organizations Struggle to Hire Leaders in 2026

The home health industry is growing rapidly across the United States, driven by an aging…

June 18, 2026
Scroll to Top